The city’s new Medical Devices Commercialization Centre has appointed Richard Meadows as its first chief operating officer, the centre announced on Wednesday.
Mr. Meadows comes to the centre with experience in commercialization of medical devices in the biopharmaceutical industry, including stints with major companies such as Bristol Myers and Procter & Gamble.
He was CEO of DERMACOR, the first wound care company in Canada, and most recently has been involved with venture capital firms investing in the life sciences sector.
(Sponsored)
How The Ottawa Hospital uses AI tools to boost health outcomes and streamline clinical efficiency
Dr. Douglas Manuel says it all began with the Ottawa Ankle Rules algorithm, a set of clinical guidelines developed in the early 1990s by The Ottawa Hospital’s Dr. Ian Stiell
Local businesses face hiring obstacles due to immigration pullback, flawed screening
In his 39 years of practicing immigration law, Warren Creates (a rare Law Society Certified Specialist) has never seen an environment so challenging for employers looking to hire workers from
In 2013, Forbes magazine recognized Mr. Meadows, who co-founded the CTI Life Sciences Fund, as one of the top 10 life sciences investors in North America.
